Sulfonylurea adherence and glycemic control in native Americans with type 2 diabetes mellitus

Michael W. Kruse, Michael S. Monaghan, Thomas J. Troshynski

Research output: Contribution to journalArticle


The purpose of this study was to assess adherence to sulfonylurea monotherapy within a Native American population with type 2 diabetes mellitus. Patient medication adherence was evaluated using medical records to perform a 12-month, cross-sectional evaluation of medication refills. Adherence was defined using a continuous, multiple-interval measure of medication availability (CMA). Patients had an average of 80.5 ± 25.4 days of medication during 100 days of treatment, equivalent to a defined adherence scale of fair to poor in 58%. Because CMA may be less expensive and time- consuming than other measures of medication adherence, CMA can be used to assess medication adherence in patients at risk for developing diabetes complications, such as Native Americans.

Original languageEnglish (US)
Pages (from-to)41-49
Number of pages9
JournalJournal of Pharmacoepidemiology
Issue number1
StatePublished - Jan 1 2000


All Science Journal Classification (ASJC) codes

  • Pharmacology, Toxicology and Pharmaceutics(all)
  • Pharmacology (medical)

Cite this